← Back to headlines
Eli Lilly's Retatrutide Shows Strong Phase 3 Trial Results
CNBC reports that Eli Lilly has announced robust Phase 3 trial results for its drug Retatrutide, indicating promising efficacy.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
US Pauses Iran Strikes Amid Houthi Clashes with Saudis
just now
Report projects 16 million Nigerians to face hunger crisis by January 2027
just now
Nigerian Vice-President Shettima urges Africa to end raw material exports
just now
Kano digital market projected to create 100,000 jobs and N50bn revenue
just now